Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Schneider, L. S. Articles by the Sertraline Elderly Depression Study Group, Search for Related Content PubMed Citation Articles by Schneider, L. S. Articles by the Sertraline Elderly Depression Study Group, Geriatric Psychiatry Depression Antidepressants

An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major Depression

OBJECTIVE: There have been few placebo-controlled trials of selective serotonin reuptake inhibitors for depressed elderly patients. This placebo-controlled study of sertraline was designed to confirm the results of non-placebo-controlled trials. METHOD: The subjects were outpatients age 60 years or older who had a DSM-IV diagnosis of major depressive disorder and a total score on the 17-item Hamilton Depression Rating Scale of 18 or higher. The patients were randomly assigned to 8 weeks of double-blind treatment with placebo or a flexible daily dose of 50 or 100 mg of sertraline. The primary outcome variables were the Hamilton scale and Clinical Global Impression (CGI) scales for severity and improvement. RESULTS: A total of 371 patients assigned to sertraline and 376 assigned to placebo took at least one dose. At endpoint, the patients receiving sertraline evidenced significantly greater improvements than those receiving placebo on the Hamilton depression scale and CGI severity and improvement scales. The mean changes from baseline to endpoint in Hamilton score were –7.4 points (SD=6.3) for sertraline and –6.6 points (SD=6.4) for placebo. The rate of CGI-defined response at endpoint was significantly higher for sertraline (45%) than for placebo (35%), and the time to sustained response was significantly shorter for sertraline (median, 57 versus 61 days). There were few discontinuations due to treatment-related adverse events, 8% for sertraline and 2% for placebo. CONCLUSIONS: Sertraline was effective and well tolerated by older adults with major depression, although the drug-placebo difference was not large in this 8-week trial.

This article has been cited by other articles:

				J. C. Nelson, K. Delucchi, and L. S. Schneider Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence Am J Geriatr Psychiatry, July 1, 2008; 16(7): 558 - 567. [Abstract] [Full Text] [PDF]

				A. Bose, D. Li, and C. Gandhi Escitalopram in the Acute Treatment of Depressed Patients Aged 60 Years or Older Am J Geriatr Psychiatry, January 1, 2008; 16(1): 14 - 20. [Abstract] [Full Text] [PDF]

				J. R. Sneed, B. R. Rutherford, D. Rindskopf, D. T. Lane, H. A. Sackeim, and S. P. Roose Design Makes a Difference: A Meta-Analysis of Antidepressant Response Rates in Placebo-Controlled Versus Comparator Trials in Late-Life Depression Am J Geriatr Psychiatry, January 1, 2008; 16(1): 65 - 73. [Abstract] [Full Text] [PDF]

				B. S. Meyers Optimizing the Use of Data Generated by Geriatric Depression Treatment Studies During a Time of Diminishing Resources Am J Geriatr Psychiatry, July 1, 2007; 15(7): 545 - 552. [Full Text] [PDF]

				J. C. Nelson, K. Delucchi, and L. Schneider Suicidal Thinking and Behavior During Treatment With Sertraline in Late-Life Depression Am J Geriatr Psychiatry, July 1, 2007; 15(7): 573 - 580. [Abstract] [Full Text] [PDF]

				F. Lesperance, N. Frasure-Smith, D. Koszycki, M.-A. Laliberte, L. T. van Zyl, B. Baker, J. R. Swenson, K. Ghatavi, B. L. Abramson, P. Dorian, et al. Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial JAMA, January 24, 2007; 297(4): 367 - 379. [Abstract] [Full Text] [PDF]

				B. W. Rovner, R. Pasternak, and R. Casten A Pilot Study of Sertraline for Depression in Age-Related Macular Degeneration Am J Geriatr Psychiatry, August 1, 2006; 14(8): 718 - 719. [Full Text] [PDF]

				A. Schatzberg and S. Roose A Double-Blind, Placebo-Controlled Study of Venlafaxine and Fluoxetine in Geriatric Outpatients With Major Depression Am J Geriatr Psychiatry, April 1, 2006; 14(4): 361 - 370. [Abstract] [Full Text] [PDF]

				C. F. Reynolds III, M. A. Dew, B. G. Pollock, B. H. Mulsant, E. Frank, M. D. Miller, P. R. Houck, S. Mazumdar, M. A. Butters, J. A. Stack, et al. Maintenance treatment of major depression in old age. N. Engl. J. Med., March 16, 2006; 354(11): 1130 - 1138. [Abstract] [Full Text] [PDF]

				S. Kasper, H. de Swart, and H. Friis Andersen Escitalopram in the Treatment of Depressed Elderly Patients Am J Geriatr Psychiatry, October 1, 2005; 13(10): 884 - 891. [Abstract] [Full Text] [PDF]

				F. E. Lotrich and B. G. Pollock Aging and Clinical Pharmacology: Implications for Antidepressants J. Clin. Pharmacol., October 1, 2005; 45(10): 1106 - 1122. [Abstract] [Full Text] [PDF]

				J. C. Nelson, C. M. Clary, A. C. Leon, and L. S. Schneider Symptoms of Late-Life Depression: Frequency and Change During Treatment Am J Geriatr Psychiatry, June 1, 2005; 13(6): 520 - 526. [Abstract] [Full Text] [PDF]

				D.P. Devanand, M. S. Nobler, J. Cheng, N. Turret, G. H. Pelton, S. P. Roose, and H. A. Sackeim Randomized, Double-Blind, Placebo-Controlled Trial of Fluoxetine Treatment for Elderly Patients With Dysthymic Disorder Am J Geriatr Psychiatry, January 1, 2005; 13(1): 59 - 68. [Abstract] [Full Text] [PDF]

				D. P. Devanand, N. Juszczak, M. S. Nobler, N. Turret, L. Fitzsimons, H. A. Sackeim, and S. P. Roose An Open Treatment Trial of Venlafaxine for Elderly Patients With Dysthymic Disorder J Geriatr Psychiatry Neurol, December 1, 2004; 17(4): 219 - 224. [Abstract] [PDF]

				S. P. Roose, H. A. Sackeim, K. R. R. Krishnan, B. G. Pollock, G. Alexopoulos, H. Lavretsky, I. R. Katz, H. Hakkarainen, and Old-Old Depression Study Group Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled Trial Am J Psychiatry, November 1, 2004; 161(11): 2050 - 2059. [Abstract] [Full Text] [PDF]

				B. D. Lebowitz Clinical Trials in Late Life: New Science in Old Paradigms Gerontologist, August 1, 2004; 44(4): 452 - 458. [Abstract] [Full Text] [PDF]

				Correction Am J Psychiatry, June 1, 2004; 161(6): 1145 - 1145. [Full Text] [PDF]

				B. J. CARROLL Correction Am J Psychiatry, June 1, 2004; 161(6): 1145 - 1146. [Full Text] [PDF]

				L. S Schneider Venlafaxine offers no benefit over sertraline and is less well tolerated in depressed nursing home residents Evid. Based Ment. Health, May 1, 2004; 7(2): 47 - 47. [Full Text] [PDF]

				B. J. CARROLL Sertraline and the Cheshire Cat in Geriatric Depression Am J Psychiatry, April 1, 2004; 161(4): 759 - 759. [Full Text]

				Other articles noted Evid. Based Ment. Health, February 1, 2004; 7(1): 3 - 4. [Full Text] [PDF]

				Other articles noted: 25 Jul 03 to 7 Nov 03 Evid. Based Nurs., January 1, 2004; 7(1): e1 - 1. [Full Text] [PDF]

				Sertraline for Elders with Major Depression -- A Modest Effect Journal Watch Psychiatry, September 18, 2003; 2003(918): 14 - 14. [Full Text]

				Sertraline for Elders with Major Depression -- A Modest Effect Journal Watch (General), August 12, 2003; 2003(812): 4 - 4. [Full Text]

				J. Rosack Psychiatr News, August 1, 2003; 38(15): 26 - 26. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us